FTFuture Technology
HARDWARE

Oura Files to Go Public as Smart Ring Revenue Climbs

· 3 min read · By Nath Connell

Key takeaways

  • Oura has officially filed to go public, confirming years of IPO speculation
  • The company reports significant revenue growth over the past year, though specific figures await the full prospectus
  • Oura rings are priced between 299 and 349 dollars, with a six dollar monthly membership fee for full features
  • Oura's sleep tracking is consistently rated among the most accurate consumer-grade options in independent comparisons

Oura, the Finnish company behind the smart ring that has become something of a status symbol among health-conscious professionals, has filed to go public. The company has not yet published a full prospectus with specific revenue figures, but it says its business has shown significant revenue growth over the past year. After years of speculation about an Oura IPO, the filing makes it official: the smart ring market is mature enough to support a publicly traded company.

Oura's journey from niche biometric device to mainstream health wearable has been one of the more interesting hardware stories of the past decade. The ring measures sleep stages, heart rate variability, blood oxygen, skin temperature, and activity, and it does so in a form factor that many users find more comfortable and less obtrusive than a smartwatch. The third-generation ring launched in 2021, and the company has been iterating on both hardware and software since, most recently adding AI-powered health insights that interpret the raw data into actionable guidance.

What Makes Oura Different in a Crowded Market

The wearables market is genuinely competitive. Apple Watch dominates the premium smartwatch segment. Garmin owns the serious fitness tracking space. Whoop has carved out a subscription-first position for serious athletes. Fitbit, now part of Google, has been steadily losing relevance. Into this landscape, Oura has managed to maintain a distinct identity based on three things: design, sleep tracking accuracy, and the absence of a screen.

That last point sounds counterintuitive as a selling feature, but it turns out a lot of people want health data without the distraction of notifications, apps, and the general insistence of a smartwatch that you pay attention to it. The ring sits on your finger, measures things continuously, and syncs to your phone when you want to look at the data. For users who find smartwatches socially or professionally inconvenient, or who simply prefer something more jewellery-adjacent, it is a compelling alternative.

Oura's sleep tracking is frequently cited in independent comparisons as among the most accurate consumer-grade options available, and sleep data has become the entry point through which many users engage with health monitoring more broadly. Once you understand your sleep cycles, resting heart rate trends, and recovery scores, you start paying attention to what affects them: alcohol, stress, exercise timing, caffeine. The ring becomes a lens for health behaviour generally, not just a single-metric device.

The future, in 3 minutes a day. The biggest tech story explained every morning, free. Get the briefing →

The Subscription Question

Oura charges a membership fee of around six dollars per month on top of the hardware purchase price, which is currently between 299 and 349 dollars for the ring itself. That subscription model is both a financial asset and a potential friction point in an IPO context. Investors like recurring revenue. Consumers sometimes resent being charged monthly for features that seem like they should be part of the product they already bought.

The company has navigated this partly by keeping the hardware price stable while expanding the subscription features, so the value proposition of the membership has improved over time. But the subscription debate is one that will come up in analyst questions during any IPO roadshow, and Oura will need a compelling answer about how it grows that subscriber base and reduces churn.

The Market Context

An Oura IPO would arrive at an interesting moment for health tech. Consumer interest in continuous health monitoring has increased substantially since the pandemic, and the category has attracted serious institutional and retail investor attention. At the same time, health tech as a sector has had some high-profile stumbles: Peloton's trajectory is the obvious cautionary tale, and Fitbit's absorption into Google without much apparent impact on either company is another.

What Oura has that many health tech companies lacked is a product with genuine, measurable utility and a loyal user base that talks about it. The ring's word-of-mouth reputation is unusually strong for a hardware product in this price range. That social proof is valuable, but it does not automatically translate into the kind of top-line growth that public market investors expect from a tech company going public in 2026.

The filing is the beginning of a process that will take months. The prospectus, when it is published with full financial details, will tell us a great deal more about whether Oura's growth trajectory matches its valuation expectations. For now, the smart ring has made it to the starting line of public markets.

Sources

Get the briefing, free

The biggest tech story, explained in 3 minutes every weekday. Choose your briefings →

Free. No spam. Unsubscribe in one click.